GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, FABP3, HMGCR, HSD17B2, IGF1R, MAOB, MMP2, MMP9, NR3C1, OPRK1, OPRM1, PDE3A, PDE3B, PPARA, RORC, SRC, TYR |
11.1969 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TYR |
10.5907 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CBR1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD2, FABP3, FABP4, FUT7, HMGCR, HSD17B1, HSD17B2, MET, MIF, PDE3A, PPARA |
10.2118 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, FUT7, HMGCR, MIF, PDE10A, PDE3A, PDE3B, PDE5A, PIM1, PPARA, TYR, XDH |
10.1157 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, FABP3, FABP4, FLT3, HMGCR, HSD17B2, IGF1R, KDR, MAOB, MMP2, NR3C1, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PPARA, RORC, SRC, TYR |
10.1157 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, FABP3, FABP4, FLT3, HMGCR, HSD17B2, HTR2A, IGF1R, KDR, MAOB, MMP2, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PPARA, RORC, SRC, TERT, TYR |
9.90465 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APP, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, FLT3, MAOB, NR3C1, OPRK1, OPRM1, PDE3A, RORC, SRC, TYR |
9.46292 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, FLT3, HCAR2, HMGCR, HTR2A, KDR, MET, MIF, MMP12, MMP9, OPRK1, OPRM1, PDE5A, PTPN1, SRC, TERT, XDH |
9.12432 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, FLT3, HCAR2, HMGCR, HTR2A, KDR, MET, MIF, MMP12, MMP9, OPRK1, OPRM1, PDE5A, PTPN1, SRC, TERT, XDH |
9.1156 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, APP, AR, BCL2, CDC25B, CSNK2A1, CYP1B1, DRD2, FABP3, FLT3, HMGCR, HTR1A, HTR2A, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, OPRM1, PDE5A, PGR, PIM1, SRC, TERT, XDH |
8.42455 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, MIF |
8.32605 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, MIF |
8.08898 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APP, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DRD1, FABP3, FLT3, IGF1R, MAOB, MMP2, NR3C1, OPRK1, OPRM1, PDE3A, PDE3B, PPARA, SRC |
8.08898 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AR, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, FABP3, FLT3, HSD17B2, MAOB, NR3C1, OPRK1, OPRM1, RORC, SRC, TYR |
7.82702 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, FABP3, FABP4, FLT3, HCAR2, HMGCR, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR7, KDR, MAOB, MET, MIF, OPRD1, OPRK1, OPRM1, PDE3A, PPARA, SRC, TERT, XDH |
7.82702 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, FABP3, FLT3, HCAR2, HMGCR, HTR1A, HTR2A, IGF1R, KDR, MAOB, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PDE3A, PDE5A, PGR, PIM1, PPARA, PTPN1, RORC, SRC, TERT, XDH |
7.60021 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CBR1, CES2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD2, FABP3, FABP4, FUT7, HMGCR, MET, MIF, PDE3A, PPARA |
7.46975 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, DRD1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, RORC, SRC, TERT |
7.15982 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, HMGCR, HSD17B1, HSD17B2 |
6.94677 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, MAOB, MMP9, SRC, TERT |
6.89953 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, FABP3, FABP4, FLT3, FUT7, HMGCR, HSD17B1, HSD17B2, HTR1A, IGF1R, KDR, MAOB, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PDE10A, PDE3A, PDE3B, PDE5A, PGR, PIM1, PPARA, PTPN1, RORC, SENP6, SRC, TERT, TYR, XDH |
6.86063 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, BCL2, CA9, CYP1A1, CYP1B1, DRD1, DRD2, FABP3, HMGCR, HTR2A, KDR, MAOB, NR3C1, OPRK1, OPRM1, PDE3A, SRC |
6.86063 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CYP1A1, CYP1B1, DRD1, DRD2, HMGCR, KDR, MAOB, OPRD1, OPRK1, SRC |
6.71839 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.71839 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, HCAR2, HMGCR, HTR1A, HTR2A, IGF1R, KDR, MAOB, MET, MIF, MMP12, MMP9, OPRD1, OPRK1, OPRM1, PPARA, PTPN1, SRC, TERT |
6.7096 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, FABP3, FABP4, FLT3, FUT7, HMGCR, HSD17B1, HSD17B2, HTR1A, IGF1R, KDR, MAOB, MET, MIF, MMP1, MMP2, NR3C1, NR3C2, PDE10A, PDE3A, PDE3B, PDE5A, PGR, PIM1, PPARA, PTPN1, RORC, SENP6, SRC, TERT, TYR, XDH |
6.6848 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, MIF |
6.68377 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AR, AXL, BCL2, CYP1B1, DRD2, FLT3, HMGCR, HTR2A, KDR, MET, MIF, OPRK1, OPRM1, PDE5A, PTPN1, SRC, XDH |
6.6823 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CYP1A1, CYP1B1, DRD1, FABP4, FLT3, IGF1R, KDR, MMP2, NR3C1, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, RORC, SRC |
6.64246 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, APP, AR, BCL2, CDC25B, DRD1, DRD2, FABP3, FLT3, HMGCR, HTR2A, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PDE5A, PTPN1, SRC, XDH |
6.63197 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, APP, AR, BCL2, CDC25B, DRD1, DRD2, FABP3, FLT3, HMGCR, HTR2A, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PDE5A, PTPN1, SRC, XDH |
6.63197 |
[BP] GO:0007193 |
None
|
ADORA1, CHRM2, DRD2, HTR1A, HTR7, OPRD1, OPRK1, OPRM1 |
6.6299 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CBR1, CDC25B, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, FABP4, FLT3, FUT7, HMGCR, HSD17B2, HTR2A, KDR, MAOB, MET, MIF, MMP2, MMP9, PDE3A, PDE3B, PGR, PIM1, PPARA, RORC, SIGMAR1, SRC, TERT, TYR |
6.49838 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, APP, AR, DRD2, FLT3, HMGCR, HTR2A, KDR, MIF, OPRK1, OPRM1, PDE5A, PTPN1, SRC, XDH |
6.48616 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, APP, AR, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, FLT3, HMGCR, HTR2A, KDR, MET, MIF, MMP12, MMP9, OPRK1, OPRM1, PDE5A, PTPN1, SRC, TERT, XDH |
6.44684 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, FABP3, FABP4, FLT3, HCAR2, HMGCR, HTR1A, HTR2A, IGF1R, KDR, MAOB, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PDE3A, PDE5A, PGR, PIM1, PPARA, PTPN1, RORC, SRC, TERT, XDH |
6.40068 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AR, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, FABP4, HMGCR, HSD17B2, HTR1A, HTR2A, HTR7, IGF1R, MET, MMP1, MMP12, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PDE5A, PIM1, PPARA, RORC, SRC, TYR |
6.36288 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, FLT3, HMGCR, HTR2A, IGF1R, KDR, MET, MIF, MMP9, OPRK1, OPRM1, PDE10A, PDE3B, PDE5A, PTPN1, SRC, XDH |
6.33558 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, MIF, PPARA |
6.30363 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AURKB, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, FABP3, FABP4, FUT7, MAOB, MMP1, MMP12, MMP2, MMP9, PDE10A, PDE3A, PDE3B, PDE5A, SRC, XDH |
6.28648 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
6.26043 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, FABP3, FABP4, FLT3, HMGCR, HSD17B2, HTR1A, HTR2A, IGF1R, KDR, MAOB, MIF, MMP12, MMP2, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PPARA, PTPN1, RORC, SRC, TERT, TYR |
6.23428 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, APP, AR, BCL2, CDC25B, DRD2, FLT3, HMGCR, HTR2A, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PDE5A, PTPN1, SRC, XDH |
6.2285 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PDE3A, PIM1, PPARA, PTPN1, SRC, TERT |
6.1987 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, FLT3, HCAR2, HMGCR, HTR1A, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, OPRK1, OPRM1, PDE10A, PDE3B, PDE5A, PTPN1, SRC, TERT, XDH |
6.08451 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, DRD1, DRD2, HCAR2, HMGCR, HTR2A, KDR, MIF, OPRK1, SRC |
6.04531 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, FABP3, FLT3, MAOB, NR3C1, OPRK1, PDE3B, PPARA, SRC |
6.03809 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PDE3A, PIM1, PTPN1, SRC, TERT |
6.02609 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, FLT3, HCAR2, HMGCR, HTR1A, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, OPRK1, OPRM1, PDE10A, PDE3B, PDE5A, PTPN1, SRC, TERT, XDH |
5.98542 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, APP, AR, BCL2, CDC25B, DRD2, FLT3, HMGCR, HTR2A, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PDE5A, PTPN1, SRC, XDH |
5.9781 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, HCAR2, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PDE3A, PIM1, PPARA, PTPN1, SIGMAR1, SRC, TERT, XDH |
5.9312 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AR, BCL2, CDC25B, CSNK2A1, DRD2, FLT3, HMGCR, HTR1A, HTR2A, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PIM1, TERT |
5.92945 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, APP, AR, BCL2, CDC25B, DRD1, DRD2, FABP4, FLT3, HMGCR, HTR2A, IGF1R, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PDE5A, PPARA, PTPN1, SRC, XDH |
5.92675 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, DRD1, DRD2, HMGCR, HTR2A, MMP2, OPRD1, OPRK1, OPRM1, PPARA, SRC, TERT, TYR |
5.90501 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, APP, AR, BCL2, CDC25B, DRD1, DRD2, FABP4, FLT3, HMGCR, HTR2A, IGF1R, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PDE5A, PTPN1, SRC, XDH |
5.88865 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.87694 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, HCAR2, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PDE3A, PIM1, PTPN1, SIGMAR1, SRC, TERT, XDH |
5.86461 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, HMGCR, HTR1A, MAOB, TYR |
5.86096 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, DRD2, HCAR2, HMGCR, HSD17B1, HSD17B2, HTR1A, HTR2A, OPRK1 |
5.75611 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.71815 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.71815 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, FABP4, FLT3, IGF1R, KDR, MIF, MMP2, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PTPN1, RORC, SRC, TERT |
5.71815 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, APP, BCL2, CA2, CA7, DRD1, DRD2, HTR1A, HTR2A, MAOB, MIF, MMP9, OPRD1, OPRK1, OPRM1 |
5.71434 |
[BP] GO:0007188 |
None
|
ADORA1, CHRM2, DRD1, DRD2, HTR1A, HTR7, OPRD1, OPRK1, OPRM1 |
5.69584 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, AR, CYP1A1, CYP1B1, DRD1, FLT3, NR3C1, OPRM1, PDE3A, RORC, SRC |
5.69584 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, APP, AXL, BCL2, CA2, CA7, CYP19A1, DRD1, DRD2, HCAR2, HMGCR, HTR1A, HTR2A, MAOB, MIF, MMP12, MMP9, OPRD1, OPRK1, OPRM1, PPARA, PTPN1, SRC, TERT |
5.66583 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, APP, AR, DRD2, FLT3, HMGCR, HTR2A, IGF1R, KDR, MIF, OPRK1, OPRM1, PDE5A, PTPN1, SRC, XDH |
5.65271 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, HTR7, OPRK1, OPRM1, PGR, PPARA, RORC, SRC |
5.62838 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, APP, AR, BCL2, CDC25B, DRD1, DRD2, FABP3, FABP4, FLT3, HMGCR, HTR2A, IGF1R, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PDE5A, PPARA, PTPN1, SRC, XDH |
5.55873 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, FABP3, FABP4, HMGCR, HTR2A, IGF1R, KDR, MAOB, MET, MIF, MMP12, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PDE5A, PIM1, PPARA, PTPN1, RORC, SRC, TERT, XDH |
5.50166 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, APP, AR, BCL2, CDC25B, DRD1, DRD2, FABP3, FABP4, FLT3, HMGCR, HTR2A, IGF1R, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PDE5A, PPARA, PTPN1, SRC, XDH |
5.50166 |
[BP] GO:0038003 |
None
|
OPRD1, OPRK1, OPRM1, SIGMAR1 |
5.50166 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.50166 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, APP, AR, AXL, BCL2, CA1, CA2, CHRM2, CSNK2A1, CYP1B1, DRD1, DRD2, FLT3, HCAR2, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, MIF, MMP2, MMP9, NR3C1, NR3C2, OPRD1, OPRK1, OPRM1, PDE10A, PDE3A, PDE3B, PDE5A, PGR, PIM1, PPARA, PTPN1, RORC, SIGMAR1, SRC |
5.48009 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, HMGCR, IGF1R, KDR, MIF, MMP9, PDE3A, PIM1, PTPN1, SRC, TERT |
5.46754 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2, HTR1A, MAOB, TYR |
5.39671 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, HCAR2, HMGCR, IGF1R, KDR, MIF, MMP9, PDE3A, PIM1, PTPN1, SIGMAR1, SRC, TERT, XDH |
5.35428 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, FLT3, HMGCR, HTR2A, IGF1R, KDR, MAOB, MET, MIF, MMP12, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PDE5A, PGR, PPARA, PTPN1, RORC, SRC, TERT, XDH |
5.35428 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, FABP3, FABP4, HCAR2, HMGCR, HTR2A, IGF1R, KDR, MAOB, MET, MIF, MMP12, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PDE5A, PGR, PIM1, PPARA, PTPN1, RORC, SRC, TERT, XDH |
5.35428 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HMGCR, HSD17B1, HSD17B2, MAOB, TYR, XDH |
5.20677 |
[BP] GO:0007187 |
None
|
ADORA1, CHRM2, DRD1, DRD2, HTR1A, HTR7, OPRD1, OPRK1, OPRM1 |
5.20677 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, AR, BCL2, DRD1, DRD2, HMGCR, HTR2A, IGF1R, MET, MIF, MMP12, MMP9, OPRK1, OPRM1, PDE3B, PTPN1, SRC, TERT, XDH |
5.11018 |
[BP] GO:0007200 |
None
|
CHRM2, DRD1, DRD2, HTR2A, OPRD1, OPRK1, OPRM1 |
5.10297 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, AR, BCL2, DRD1, DRD2, HMGCR, HTR2A, IGF1R, MET, MIF, MMP12, MMP9, OPRK1, OPRM1, PDE3B, PTPN1, SRC, TERT, XDH |
5.09619 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AR, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, FABP4, FLT3, HMGCR, HTR2A, KDR, MET, MIF, MMP12, MMP2, MMP9, OPRK1, OPRM1, PDE5A, PTPN1, SRC, TERT, XDH |
5.06526 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, APP, AR, AURKB, BCL2, CDC25B, DRD1, DRD2, FABP3, FLT3, HMGCR, HTR2A, IGF1R, KDR, MAOB, MET, MIF, MMP12, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PDE5A, PGR, PPARA, PTPN1, RORC, SRC, TERT, XDH |
5.01042 |
[BP] GO:0030534 |
None
|
APP, DRD1, DRD2, HTR2A, OPRD1, OPRK1, OPRM1, PPARA |
4.953 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, APP, AR, BCL2, CDC25B, DRD2, FLT3, HMGCR, HTR2A, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PDE5A, PTPN1, SRC, XDH |
4.82375 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, FABP3, FLT3, HMGCR, HTR2A, IGF1R, KDR, MAOB, MET, MIF, MMP12, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PDE5A, PGR, PPARA, PTPN1, RORC, SRC, TERT, XDH |
4.82114 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, DRD1, DRD2, HTR2A, KDR, SRC |
4.77269 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
4.72588 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, FABP3, FLT3, HCAR2, HMGCR, HTR2A, PDE3B, PPARA, RORC, SRC |
4.67933 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AR, AXL, CYP1B1, DRD1, IGF1R, MMP2, MMP9, NR3C1, OPRK1, PDE3A, PDE3B, RORC, SRC |
4.66469 |
[BP] GO:0003018 |
None
|
ADORA1, DRD1, HMGCR, HTR1A, HTR2A, HTR7, PDE3A, SRC |
4.64436 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, DRD1, DRD2, FABP3, FLT3, IGF1R, MMP2, OPRK1, OPRM1, PDE3A, PDE3B, PPARA, SRC, TYR |
4.62381 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AR, AXL, BCL2, CA2, CYP1B1, DRD2, HCAR2, HMGCR, HTR2A, KDR, MET, MIF, MMP12, MMP9, OPRM1, PDE3A, PDE5A, PIM1, SRC, TERT |
4.59779 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, IGF1R, KDR, MET, MIF, MMP9, SRC, TERT |
4.54337 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, IGF1R, KDR, MET, MIF, MMP9, OPRK1, SRC, TERT |
4.52531 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AR, AURKB, AXL, BCL2, CBR1, CDC25B, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, FABP3, FABP4, FLT3, FUT7, HMGCR, HSD17B1, HSD17B2, HTR1A, IGF1R, KDR, MAOB, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PDE10A, PDE3A, PDE3B, PDE5A, PGR, PIM1, PPARA, PTPN1, RORC, SENP6, SRC, TERT, TYR, XDH |
4.46598 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.45517 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, APP, CA2, CHRM2, DRD1, DRD2, HCAR2, HTR1A, HTR2A, HTR7, OPRD1, OPRK1, OPRM1, PDE10A, PDE3A, PDE3B, SIGMAR1, SRC |
4.45517 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, FLT3, HMGCR, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PDE5A, PGR, PPARA, PTPN1, RORC, SRC, TERT, XDH |
4.44377 |
[BP] GO:0032787 |
None
|
ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, MIF, PPARA |
4.4372 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CYP19A1, DRD2, HCAR2, HMGCR, HTR1A, HTR2A, MAOB, MIF, MMP12, OPRK1, OPRM1, SRC |
4.43168 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6, RORC |
4.40048 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CES2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, FABP3, FABP4, FLT3, FUT7, HCAR2, HMGCR, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR7, IGF1R, KDR, MAOB, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, OPRD1, OPRK1, OPRM1, PDE10A, PDE3A, PDE3B, PDE5A, PGR, PIM1, PPARA, PTPN1, RORC, SENP6, SIGMAR1, SRC, TERT, TYR, XDH |
4.30629 |
[BP] GO:0010038 |
response to metal ion
|
APP, BCL2, CA2, CYP1A1, CYP1A2, DRD2, FABP4, MAOB, MMP9, TERT |
4.28759 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, APP, AR, BCL2, CDC25B, DRD1, DRD2, FABP4, FLT3, HMGCR, HTR2A, IGF1R, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PDE5A, PTPN1, SRC, XDH |
4.26526 |
[BP] GO:0097756 |
None
|
ADORA1, HMGCR, HTR1A, HTR2A, HTR7 |
4.2648 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, DRD1, DRD2, FABP3, FLT3, IGF1R, MMP2, OPRK1, OPRM1, PDE3A, PDE3B, PPARA, SRC, TYR |
4.26456 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, IGF1R, KDR, MET, MIF, MMP9, SRC, TERT |
4.25421 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AR, AURKB, AXL, BCL2, CBR1, CDC25B, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, FABP3, FABP4, FLT3, FUT7, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PDE10A, PDE3A, PDE3B, PDE5A, PGR, PIM1, PPARA, PTPN1, RORC, SENP6, SRC, TERT, TYR, XDH |
4.23145 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2, HTR1A, MAOB |
4.19244 |
[BP] GO:0009214 |
None
|
PDE10A, PDE3A, PDE3B, PDE5A |
4.18951 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HMGCR, PDE3A |
4.16766 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, FLT3, HMGCR, IGF1R, KDR, MET, PDE10A, PDE3A, PDE3B, PDE5A, PIM1, PTPN1, SRC, XDH |
4.15412 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, HCAR2, HMGCR, HTR1A, HTR2A, MAOB, MIF, MMP12, OPRK1, OPRM1, SRC |
4.10008 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, OPRD1, PPARA, SRC, TERT |
4.0898 |
[BP] GO:0006195 |
None
|
PDE10A, PDE3A, PDE3B, PDE5A, XDH |
4.07954 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, NR3C1, NR3C2, PGR, PPARA, RORC, SRC |
4.06655 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, DRD1, DRD2, MAOB |
4.05445 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, APP, AR, AXL, BCL2, CA2, CHRM2, CYP1B1, DRD2, HCAR2, HMGCR, HTR2A, KDR, MET, MIF, MMP12, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PDE5A, PIM1, SRC, TERT, XDH |
3.99928 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, OPRD1, PPARA, SRC, TERT |
3.99928 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
APP, DRD2, HMGCR, HTR2A, KDR, MIF, OPRM1, SRC |
3.9719 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, HTR2A, OPRK1 |
3.92727 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
APP, DRD2, HMGCR, HTR2A, KDR, MIF, OPRM1, PTPN1, SRC |
3.91933 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, IGF1R, KDR, MET, MIF, MMP9, SRC, TERT |
3.86155 |
[BP] GO:0003013 |
None
|
ADORA1, DRD1, HMGCR, HTR1A, HTR2A, HTR7, PDE3A, SRC |
3.86038 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT |
3.86038 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, FLT3, HMGCR, IGF1R, KDR, MET, PDE10A, PDE3A, PDE3B, PDE5A, PIM1, PTPN1, SRC, XDH |
3.85301 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APP, AR, AURKB, BCL2, CSNK2A1, CYP2D6, DRD2, FABP4, HCAR2, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, OPRD1, OPRM1, PDE3B, PGR, PPARA, PTPN1, RORC, SRC, TERT, XDH |
3.83129 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, DRD2, HMGCR, HTR2A, MIF, SRC |
3.81024 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, CYP2D6, DRD2, FABP4, HMGCR, IGF1R, MET, MMP9, OPRM1, PIM1, PPARA, PTPN1, SRC |
3.79784 |
[BP] GO:0072523 |
None
|
PDE10A, PDE3A, PDE3B, PDE5A, XDH |
3.79729 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, OPRD1, PPARA, SRC, TERT |
3.72627 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, APP, AR, BCL2, CDC25B, CSNK2A1, DRD2, FLT3, HMGCR, HTR2A, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PDE5A, PTPN1, SRC, XDH |
3.71634 |
[BP] GO:0007631 |
None
|
APP, DRD1, DRD2, OPRD1, OPRK1, OPRM1 |
3.70783 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, AR, BCL2, CA2, FLT3, MAOB, NR3C1, SRC |
3.67325 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.63989 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1, MAOB |
3.63989 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, DRD1, HSD17B2, MMP2, MMP9, OPRK1, OPRM1, PDE3A, PGR, SRC |
3.58789 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, APP, AXL, BCL2, CA2, CYP19A1, DRD1, DRD2, HCAR2, MIF, MMP12, OPRK1, SRC, TERT |
3.50905 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, APP, AR, BCL2, CDC25B, DRD2, FLT3, HMGCR, HTR2A, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PDE5A, PTPN1, SRC, XDH |
3.47836 |
[BP] GO:0050665 |
hydrogen peroxide biosynthetic process
|
CYP1A1, CYP1A2, MAOB |
3.47505 |
[BP] GO:0003008 |
None
|
ADORA1, AKR1B1, APP, BCL2, CYP1B1, DRD1, DRD2, HMGCR, HTR1A, HTR2A, HTR7, OPRD1, OPRK1, OPRM1, PDE3A, PDE5A, SRC, TYR |
3.46765 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, PDE3A |
3.43651 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, NR3C1, NR3C2, PGR, PPARA, RORC, SRC |
3.43184 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, FLT3, HMGCR, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, OPRK1, OPRM1, PDE10A, PDE3B, PDE5A, PTPN1, SRC, TERT, XDH |
3.41985 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 |
3.41985 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, MIF, PIM1, PPARA, TYR |
3.40265 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, FABP3, FABP4, FUT7, MAOB, PDE10A, PDE3A, PDE3B, PDE5A, XDH |
3.40265 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, APP, AR, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, FABP3, FABP4, FLT3, HCAR2, HMGCR, HTR1A, HTR2A, IGF1R, KDR, MAOB, MET, MIF, MMP12, MMP9, NR3C1, NR3C2, OPRD1, OPRK1, OPRM1, PDE3B, PDE5A, PGR, PIM1, PPARA, PTPN1, RORC, SRC, TERT, XDH |
3.40265 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD2, HMGCR, IGF1R, MET, MIF, MMP9, PDE3B, PTPN1, SRC, XDH |
3.39708 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, FABP3, PPARA |
3.38757 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, FABP4, FLT3, HMGCR, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP2, MMP9, OPRK1, OPRM1, PDE10A, PDE3B, PDE5A, PPARA, PTPN1, SRC, TERT, XDH |
3.37627 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALPL, APP, AR, AXL, BCL2, CA2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, FLT3, HSD17B2, KDR, MAOB, MMP9, PGR, PIM1, PPARA, RORC, SIGMAR1, SRC, TYR |
3.37475 |
[BP] GO:0009166 |
None
|
PDE10A, PDE3A, PDE3B, PDE5A, XDH |
3.36579 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2, HTR2A |
3.33389 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, NR3C1, PGR, PIM1, PPARA, RORC, SRC |
3.32846 |
[BP] GO:0009154 |
None
|
PDE10A, PDE3A, PDE3B, PDE5A |
3.29265 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CA9, CSNK2A1, MAOB, NR3C1, SRC |
3.28615 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, BCL2, CYP1A1, DRD2, OPRM1, PPARA |
3.27223 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, FLT3, HMGCR, HTR2A, IGF1R, MIF, PDE5A, PTPN1, SRC |
3.25903 |
[BP] GO:0007610 |
None
|
APP, BCL2, DRD1, DRD2, HMGCR, HTR1A, HTR2A, OPRD1, OPRK1, OPRM1, PPARA |
3.24855 |
[BP] GO:0009261 |
None
|
PDE10A, PDE3A, PDE3B, PDE5A |
3.24855 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2, HTR2A |
3.24855 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, HTR2A, MET |
3.24203 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, CYP2D6, MET, MMP9, PPARA, SRC, TERT |
3.23852 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, BCL2, CYP1A1, FLT3, HTR1A, MET, MIF, PIM1, SRC, TYR |
3.22999 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.21336 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, DRD2 |
3.20685 |
[BP] GO:1901292 |
None
|
PDE10A, PDE3A, PDE3B, PDE5A, XDH |
3.20685 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 |
3.20456 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, FABP4, FLT3, HMGCR, HTR2A, IGF1R, MET, MIF, MMP9, OPRD1, OPRM1, PDE5A, PIM1, PPARA, PTPN1, SRC, TERT, XDH |
3.20389 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, DRD1, DRD2 |
3.19908 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, APP, AR, AXL, BCL2, CBR1, CDC25B, CYP1A1, DRD1, DRD2, FABP4, FLT3, FUT7, HMGCR, KDR, MET, MIF, MMP2, MMP9, PDE3A, PGR, RORC, SRC, TERT |
3.19067 |
[BP] GO:0046883 |
regulation of hormone secretion
|
ADORA1, CYP19A1, DRD2, HCAR2, HMGCR, HTR1A, HTR2A, OPRK1 |
3.18976 |
[BP] GO:0008306 |
None
|
APP, DRD1, DRD2, HMGCR, OPRK1 |
3.15724 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, APP, CDC25B, DRD2, FABP4, FLT3, HMGCR, HTR2A, IGF1R, MIF, PDE5A, PTPN1, SRC |
3.15128 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, FABP4, FLT3, HMGCR, HTR2A, IGF1R, MIF, MMP9, OPRM1, PDE5A, PTPN1, SRC, TERT, XDH |
3.15128 |
[BP] GO:0097746 |
None
|
ADORA1, DRD1, HMGCR, HTR1A, HTR2A, HTR7 |
3.15128 |
[BP] GO:0035296 |
None
|
ADORA1, DRD1, HMGCR, HTR1A, HTR2A, HTR7 |
3.15128 |
[BP] GO:1901361 |
None
|
CYP19A1, CYP1A1, CYP1A2, CYP2A6, MAOB, PDE10A, PDE3A, PDE3B, PDE5A, XDH |
3.13748 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, AR, BCL2, CYP19A1, DRD1, DRD2, HMGCR, IGF1R, MET, MIF, MMP12, MMP9, PDE3B, PPARA, PTPN1, SRC, TERT, XDH |
3.13748 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, APP, AR, AURKB, AXL, BCL2, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP2D6, DRD1, DRD2, FLT3, FUT7, HMGCR, HTR1A, IGF1R, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, PDE10A, PDE3A, PDE3B, PDE5A, PIM1, PPARA, PTPN1, SENP6, SRC, TYR, XDH |
3.13429 |
[BP] GO:0051930 |
None
|
ADORA1, OPRD1, OPRK1, OPRM1 |
3.12874 |
[BP] GO:0051931 |
None
|
ADORA1, OPRD1, OPRK1, OPRM1 |
3.12874 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APP, AR, DRD1, FLT3, IGF1R, MMP2, NR3C1, OPRM1, PDE3A, PDE3B, SRC |
3.08414 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.07459 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CYP1A1, CYP1A2, MAOB, OPRK1, OPRM1, SRC |
3.05425 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APP, AXL, BCL2, CA12, CA2, CA7, DRD1, DRD2, FABP3, FABP4, FLT3, HTR2A, MET, SRC, TERT |
3.05425 |
[BP] GO:0051952 |
None
|
ADORA1, DRD1, DRD2, HTR2A, OPRK1 |
3.04505 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9, TERT |
3.04505 |
[BP] GO:0050880 |
None
|
ADORA1, DRD1, HMGCR, HTR1A, HTR2A, HTR7 |
3.02296 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, MIF, PIM1, PPARA, TYR |
3.01279 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, DRD1, KDR, NR3C1, OPRM1, SRC |
3.00969 |
[BP] GO:0035150 |
None
|
ADORA1, DRD1, HMGCR, HTR1A, HTR2A, HTR7 |
3.00951 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, APP, AR, BCL2, CYP1B1, DRD2, FABP3, OPRM1, PDE5A, TERT, XDH |
2.9783 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, APP, AR, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, FABP3, FABP4, FLT3, HCAR2, HMGCR, HTR1A, HTR2A, IGF1R, KDR, MAOB, MET, MIF, MMP12, MMP9, NR3C1, NR3C2, OPRD1, OPRK1, OPRM1, PDE3B, PDE5A, PGR, PIM1, PPARA, PTPN1, RORC, SRC, TERT, XDH |
2.97644 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AKR1B10, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, FABP3, FABP4, MAOB, PDE10A, PDE3A, PDE3B, PDE5A, SRC, XDH |
2.97644 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, MIF, PIM1, PPARA, TYR |
2.93845 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, HCAR2, MIF, MMP12, OPRK1, SRC |
2.93845 |
[BP] GO:0031635 |
None
|
OPRK1, OPRM1 |
2.92144 |
[BP] GO:0007268 |
None
|
CHRM2, DRD1, DRD2, HTR2A, HTR7, OPRD1, OPRK1, OPRM1 |
2.92084 |
[BP] GO:0098916 |
None
|
CHRM2, DRD1, DRD2, HTR2A, HTR7, OPRD1, OPRK1, OPRM1 |
2.92084 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.91775 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, DRD1, IGF1R, KDR, MET, MMP9, OPRK1, SRC, TERT |
2.91775 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
AR, BCL2, MIF, MMP9, PTPN1, SRC, TERT |
2.90658 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, BCL2, DRD2, HTR2A, MAOB, MMP9 |
2.89038 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CYP1A1, CYP1A2, MAOB, OPRK1, OPRM1, SRC |
2.88654 |
[BP] GO:0051094 |
positive regulation of developmental process
|
APP, AR, AXL, BCL2, CA2, CYP1B1, DRD2, HMGCR, HTR2A, KDR, OPRM1, PDE3A, PDE5A, PIM1, SRC, TERT |
2.88365 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, APP, CDC25B, DRD2, FABP4, FLT3, HMGCR, HTR2A, IGF1R, MIF, PDE5A, PTPN1, SRC |
2.88156 |
[BP] GO:0051051 |
negative regulation of transport
|
ADORA1, APP, BCL2, DRD2, HMGCR, HTR2A, MAOB, MMP9, OPRK1, OPRM1 |
2.8668 |
[BP] GO:0099536 |
None
|
CHRM2, DRD1, DRD2, HTR2A, HTR7, OPRD1, OPRK1, OPRM1 |
2.86318 |
[BP] GO:0099537 |
None
|
CHRM2, DRD1, DRD2, HTR2A, HTR7, OPRD1, OPRK1, OPRM1 |
2.86318 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, DRD1, IGF1R, MMP2, OPRM1, PDE3A, PDE3B, SRC |
2.85148 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, DRD1, DRD2, HTR2A |
2.84878 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, DRD1, DRD2, HTR2A |
2.84878 |
[BP] GO:0006198 |
None
|
PDE10A, PDE3A, PDE3B |
2.83746 |
[BP] GO:0051967 |
None
|
ADORA1, DRD2, HTR2A |
2.83746 |
[BP] GO:0007154 |
None
|
ADORA1, AR, AXL, BCL2, CHRM2, DRD1, DRD2, HTR2A, HTR7, OPRD1, OPRK1, OPRM1, PGR |
2.79134 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, MAOB |
2.78967 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, MAOB |
2.78967 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, SRC |
2.78967 |
[BP] GO:2001023 |
None
|
DRD1, DRD2, HTR2A, MET, OPRK1 |
2.77159 |
[BP] GO:0007267 |
None
|
ADORA1, AR, CHRM2, DRD1, DRD2, HTR2A, HTR7, OPRD1, OPRK1, OPRM1, PGR |
2.76654 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, AURKB, CDC25B, DRD2, FABP4, FLT3, HMGCR, HTR2A, IGF1R, MIF, PDE5A, PTPN1, SRC |
2.74456 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, CHRM2, DRD2, HCAR2, HTR2A, OPRD1, OPRK1, OPRM1, PDE5A |
2.73057 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, APP, CYP19A1, DRD2, FABP4, HMGCR, IGF1R, MET, MIF, MMP12, MMP2, OPRK1, PPARA, PTPN1, SRC, TERT, XDH |
2.72512 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, FLT3, MAOB, NR3C1, SRC |
2.7007 |
[BP] GO:0050730 |
None
|
ADORA1, APP, FLT3, HTR2A, MIF, PTPN1, SRC |
2.7007 |
[BP] GO:0007568 |
aging
|
AURKB, BCL2, CYP1A1, HMGCR, HTR2A, MIF, TERT |
2.7007 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, APP, AR, BCL2, CSNK2A1, DRD2, HCAR2, HMGCR, MIF, MMP12, OPRM1, PTPN1, SRC, TERT |
2.69719 |
[BP] GO:0009314 |
response to radiation
|
APP, AURKB, BCL2, DRD1, DRD2, HMGCR, OPRK1, OPRM1, TYR |
2.6612 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CDC25B, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, FABP3, FABP4, FLT3, HCAR2, HMGCR, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR7, IGF1R, KDR, MAOB, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, OPRD1, OPRK1, OPRM1, PDE10A, PDE3A, PDE3B, PDE5A, PGR, PIM1, PPARA, PTPN1, RORC, SENP6, SIGMAR1, SRC, TERT, XDH |
2.6585 |
[BP] GO:0071695 |
None
|
APP, CDC25B, MMP2, PDE3A, PGR |
2.6585 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, MIF, MMP9, PTPN1, SRC |
2.6585 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, FLT3, HSD17B2, KDR, PPARA, SRC, TYR |
2.63577 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, NR3C1, NR3C2, PGR, PPARA, RORC |
2.63577 |
[BP] GO:0008542 |
None
|
APP, DRD1, DRD2, HMGCR |
2.63119 |
[BP] GO:0006939 |
None
|
DRD1, DRD2, HTR2A, HTR7 |
2.63119 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, DRD1, IGF1R, MMP2, OPRM1, PDE3A, PDE3B, SRC |
2.62502 |
[BP] GO:0043266 |
None
|
ADORA1, DRD1, DRD2, HTR2A, OPRK1 |
2.60208 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, FABP4, HMGCR, KDR, MET, MIF, MMP12, OPRM1, PPARA |
2.60119 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, FABP3, PPARA |
2.58298 |
[BP] GO:0048609 |
multicellular organismal reproductive process
|
AKR1B1, APP, AR, AXL, CYP1A1, DRD1, OPRK1, OPRM1, PGR, SRC |
2.55231 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, MAOB |
2.53545 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, DRD1, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.53545 |
[BP] GO:0060748 |
None
|
AR, PGR |
2.53545 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.53545 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA1, CA2, CA7, CA9, CDC25B, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, CYP2D6, DRD1, DRD2, FABP3, FABP4, FLT3, HCAR2, HMGCR, HTR1A, HTR2A, HTR7, IGF1R, KDR, MAOB, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, OPRD1, OPRK1, OPRM1, PDE10A, PDE3A, PDE3B, PDE5A, PGR, PIM1, PPARA, PTPN1, RORC, SENP6, SIGMAR1, SRC, TERT, XDH |
2.52865 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, APP, AR, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, FABP3, FABP4, FLT3, HMGCR, HTR1A, HTR2A, IGF1R, KDR, MAOB, MET, MIF, MMP12, MMP9, NR3C1, NR3C2, OPRD1, OPRK1, OPRM1, PDE5A, PGR, PIM1, PPARA, PTPN1, RORC, SRC, TERT, XDH |
2.52863 |
[BP] GO:0050994 |
None
|
ADORA1, HCAR2, PDE3B, PPARA |
2.51939 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, FLT3, IGF1R, KDR, MET, PIM1, SRC |
2.5176 |
[BP] GO:0021700 |
developmental maturation
|
APP, AXL, CDC25B, MMP2, PDE3A, PGR |
2.49227 |
[BP] GO:0007632 |
None
|
APP, DRD1, DRD2, HMGCR |
2.49227 |
[BP] GO:0042053 |
None
|
DRD1, HTR1A, MAOB |
2.49227 |
[BP] GO:0042069 |
None
|
DRD1, HTR1A, MAOB |
2.49227 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.49227 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, FLT3, HTR2A, MIF, PTPN1, SRC |
2.48484 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, APP, CA2, DRD2, HCAR2, HMGCR, MIF, MMP12, OPRM1, PTPN1, SRC |
2.47974 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, DRD2, HCAR2, MIF, MMP12, SRC |
2.47974 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, DRD2, HCAR2, HMGCR, MIF, MMP12, OPRM1, SRC |
2.47974 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, MMP9, SRC |
2.4769 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, IGF1R, OPRK1, PDE3B, PPARA, SRC |
2.4769 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, HTR1A, MIF, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PPARA, PTPN1, SRC, TERT |
2.44753 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.44729 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.44729 |
[BP] GO:0009187 |
None
|
PDE10A, PDE3A, PDE3B, PDE5A |
2.44729 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, DRD1, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.44729 |
[BP] GO:1903532 |
None
|
ACHE, CYP19A1, DRD2, HCAR2, MIF, MMP12, OPRK1, SRC |
2.42671 |
[BP] GO:0007626 |
None
|
APP, DRD1, DRD2, OPRD1, OPRK1, OPRM1 |
2.4221 |
[BP] GO:0023052 |
None
|
ADORA1, AR, CHRM2, DRD1, DRD2, HTR2A, HTR7, OPRD1, OPRK1, OPRM1, PGR |
2.4221 |
[BP] GO:2000243 |
None
|
AR, PDE3A, PDE5A, SRC |
2.4221 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, FLT3, HTR2A, MIF, PDE5A, PTPN1, SRC |
2.404 |
[BP] GO:0030336 |
None
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD2, MIF |
2.3962 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, APP, AR, AURKB, BCL2, CDC25B, DRD2, FLT3, HTR2A, MET, MIF, MMP9, OPRD1, PDE5A, PTPN1, SRC, TERT, XDH |
2.38228 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, DRD1, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.36781 |
[BP] GO:1903531 |
None
|
ADORA1, DRD2, HMGCR, MAOB, OPRK1, OPRM1 |
2.36694 |
[BP] GO:0042737 |
drug catabolic process
|
ACHE, CYP1A2, CYP2A6, CYP2D6, MAOB |
2.35641 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.35641 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, DRD2, HTR2A |
2.34889 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.34834 |
[BP] GO:0046434 |
None
|
PDE10A, PDE3A, PDE3B, PDE5A, XDH |
2.34224 |
[BP] GO:0050890 |
None
|
ADORA1, APP, DRD1, DRD2, HMGCR, HTR2A, OPRK1 |
2.34143 |
[BP] GO:0042698 |
ovulation cycle
|
AXL, OPRK1, OPRM1 |
2.34143 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.34143 |
[BP] GO:0050995 |
None
|
ADORA1, HCAR2, PDE3B |
2.34143 |
[BP] GO:0010564 |
regulation of cell cycle process
|
APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1A1, DRD2, MIF, PDE3A, SENP6, TERT |
2.33418 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APP, AURKB, CDC25B, CYP1A1, DRD2, MIF, SRC, TERT |
2.33356 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.32198 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AR, AXL, BCL2, CDC25B, CYP19A1, HSD17B2, PDE3A, PGR, SRC |
2.30852 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2 |
2.30772 |
[BP] GO:0007198 |
None
|
HTR1A, HTR7 |
2.30772 |
[BP] GO:0060282 |
None
|
PDE3A, PDE5A |
2.30772 |
[BP] GO:1905881 |
None
|
PDE3A, PDE5A |
2.30772 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.30772 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.29491 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, HMGCR, MIF, PPARA |
2.29233 |
[BP] GO:0070848 |
response to growth factor
|
APP, KDR, NR3C1, OPRD1, OPRM1, PDE3A, SRC |
2.29233 |
[BP] GO:2000146 |
None
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD2, MIF |
2.28379 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, AXL, CYP1B1, KDR, OPRD1 |
2.27823 |
[BP] GO:0046888 |
None
|
ADORA1, DRD2, HMGCR, OPRK1 |
2.26473 |
[BP] GO:0007210 |
None
|
HTR1A, HTR2A, HTR7 |
2.24959 |
[BP] GO:0098664 |
None
|
HTR1A, HTR2A, HTR7 |
2.24959 |
[BP] GO:0009416 |
response to light stimulus
|
APP, AURKB, BCL2, DRD1, DRD2, HMGCR, TYR |
2.24654 |
[BP] GO:0050795 |
None
|
ADORA1, DRD2, HTR1A, HTR2A |
2.24654 |
[BP] GO:0051881 |
regulation of mitochondrial membrane potential
|
BCL2, KDR, OPRD1, SRC |
2.24654 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, HTR2A, PPARA, SRC |
2.23888 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.22355 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.22355 |
[BP] GO:0050789 |
regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA1, CA2, CA7, CA9, CDC25B, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, FABP3, FABP4, FLT3, HCAR2, HMGCR, HTR1A, HTR2A, HTR7, IGF1R, KDR, MAOB, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, OPRD1, OPRK1, OPRM1, PDE10A, PDE3A, PDE3B, PDE5A, PGR, PIM1, PPARA, PTPN1, RORC, SENP6, SIGMAR1, SRC, TERT, XDH |
2.22082 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, APP, AR, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, FABP4, FLT3, HMGCR, HTR2A, IGF1R, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PDE5A, PTPN1, SRC, XDH |
2.21021 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, APP, AR, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DRD1, DRD2, FABP3, FABP4, FLT3, HMGCR, HTR1A, HTR2A, IGF1R, KDR, MAOB, MET, MIF, MMP12, MMP9, NR3C1, NR3C2, OPRD1, OPRK1, OPRM1, PDE5A, PGR, PIM1, PPARA, PTPN1, RORC, SRC, TERT, XDH |
2.2062 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, FLT3, HMGCR, HTR2A, IGF1R, MIF, PDE5A, PTPN1, SRC |
2.20208 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HMGCR, HSD17B1, HSD17B2 |
2.19729 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9, TERT |
2.16728 |
[BP] GO:0048469 |
cell maturation
|
APP, AXL, CDC25B, PDE3A, PGR |
2.16728 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
AR, BCL2, DRD2, HMGCR, IGF1R, MET, MIF, MMP12, MMP9, PDE3B, PTPN1, SRC, TERT, XDH |
2.16559 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, NR3C1, NR3C2, PGR, PPARA, RORC |
2.1645 |
[BP] GO:0051271 |
None
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD2, MIF |
2.16002 |
[BP] GO:0045597 |
positive regulation of cell differentiation
|
APP, AR, AXL, BCL2, CA2, DRD2, HTR2A, KDR, OPRM1, PDE3A, PDE5A, TERT |
2.16002 |
[BP] GO:0042391 |
None
|
ADORA1, APP, BCL2, DRD1, KDR, OPRD1, OPRM1, SRC |
2.14832 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, CDC25B, DRD2, FLT3, HTR2A, MIF, PDE5A, PTPN1, SRC |
2.14105 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, HMGCR |
2.1377 |
[BP] GO:0051048 |
None
|
ADORA1, DRD2, HMGCR, MAOB, OPRK1, OPRM1 |
2.12599 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.12599 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.12599 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.12599 |
[BP] GO:0007416 |
None
|
ACHE, APP, DRD1, DRD2 |
2.12087 |
[BP] GO:0031644 |
None
|
ADORA1, OPRD1, OPRK1, OPRM1 |
2.12087 |
[BP] GO:0042755 |
None
|
OPRD1, OPRK1, OPRM1 |
2.08002 |
[BP] GO:0033032 |
regulation of myeloid cell apoptotic process
|
BCL2, HCAR2, MIF |
2.08002 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, MAOB |
2.08002 |
[BP] GO:0014059 |
None
|
DRD2, HTR2A, OPRK1 |
2.08002 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, SRC |
2.07964 |
[BP] GO:0030198 |
extracellular matrix organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.07306 |
[BP] GO:0032872 |
regulation of stress-activated MAPK cascade
|
APP, HMGCR, IGF1R, OPRK1, PTPN1, XDH |
2.07306 |
[BP] GO:0007612 |
None
|
APP, DRD1, DRD2, HMGCR, OPRK1 |
2.06826 |
[BP] GO:0043062 |
extracellular structure organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.0668 |
[BP] GO:0070302 |
regulation of stress-activated protein kinase signaling cascade
|
APP, HMGCR, IGF1R, OPRK1, PTPN1, XDH |
2.06522 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.06262 |
[BP] GO:0040013 |
None
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD2, MIF |
2.06127 |
[BP] GO:0019098 |
None
|
APP, DRD1, OPRK1 |
2.04412 |
[BP] GO:0042310 |
None
|
HTR1A, HTR2A, HTR7 |
2.04412 |
[BP] GO:0071383 |
None
|
AR, FLT3, NR3C1, SRC |
2.04382 |
[BP] GO:0032868 |
None
|
FABP3, OPRK1, PDE3B, PPARA, SRC |
2.03322 |
[BP] GO:0051384 |
response to glucocorticoid
|
ALPL, BCL2, FLT3, MAOB, NR3C1 |
2.03322 |
[BP] GO:0019439 |
None
|
CYP1A1, CYP2A6, MAOB, PDE10A, PDE3A, PDE3B, PDE5A, XDH |
2.01271 |
[BP] GO:0050708 |
None
|
ACHE, DRD2, HCAR2, HMGCR, MIF, MMP12, OPRM1, SRC |
2.01063 |
[BP] GO:0035265 |
organ growth
|
AR, BCL2, CYP19A1 |
2.01063 |
[BP] GO:0002209 |
None
|
BCL2, DRD1, HTR1A |
2.01063 |
[BP] GO:1901661 |
None
|
AKR1B1, AKR1B10, HMGCR |
2.01063 |
[BP] GO:0001662 |
None
|
BCL2, DRD1, HTR1A |
2.01063 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, MAOB |
2.01063 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ALOX5, ALPL, APP, AR, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, FLT3, FUT7, HCAR2, HMGCR, HSD17B2, HTR1A, HTR2A, HTR7, IGF1R, KDR, MAOB, MET, MMP2, NR3C2, OPRD1, OPRK1, OPRM1, PDE10A, PDE3B, PGR, PIM1, PTPN1, SIGMAR1, SRC, TERT, TYR |
4.18342 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, AR, AURKB, BCL2, CA1, CA2, CA4, CA7, CBR1, CDC25B, CES2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, FABP3, FABP4, FLT3, FUT7, HMGCR, HSD17B1, HSD17B2, HTR2A, KDR, MAOB, MIF, MMP2, MMP9, NR3C1, NR3C2, OPRM1, PDE10A, PDE3A, PDE3B, PDE5A, PGR, PIM1, PTPN1, SENP6, SIGMAR1, SRC, TERT, TYR, XDH |
3.72404 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, CA4, CHRM2, DRD1, DRD2, FLT3, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1 |
3.72404 |
[CC] GO:0005783 |
None
|
ADORA1, APP, BCL2, CA4, CES2, CYP19A1, CYP2D6, FLT3, HMGCR, KDR, OPRM1, PDE3B, PTPN1, SIGMAR1, XDH |
3.62281 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, CHRM2, DRD1, DRD2, FLT3, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1 |
3.40265 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BCL2, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, FLT3, HMGCR, HSD17B2, NR3C2, PTPN1, SIGMAR1 |
3.2881 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ALPL, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, FLT3, FUT7, HCAR2, HMGCR, HSD17B2, HTR1A, HTR2A, HTR7, IGF1R, KDR, MAOB, MET, NR3C2, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PTPN1, SIGMAR1, SRC, TYR |
3.05425 |
[CC] GO:0031253 |
None
|
ADORA1, CA4, CA9, DRD1, DRD2, OPRD1, OPRM1, SRC |
2.73057 |
[CC] GO:0044463 |
None
|
ADORA1, AKR1B1, APP, CA4, CA9, CHRM2, DRD1, DRD2, HTR2A, OPRD1, OPRK1, OPRM1, SIGMAR1, SRC |
2.59095 |
[CC] GO:0120038 |
None
|
ADORA1, AKR1B1, APP, CA4, CA9, CHRM2, DRD1, DRD2, HTR2A, OPRD1, OPRK1, OPRM1, SIGMAR1, SRC |
2.59095 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, HMGCR, HSD17B2, NR3C2, SIGMAR1 |
2.58776 |
[CC] GO:0098793 |
None
|
ADORA1, APP, CHRM2, DRD2, OPRD1, OPRK1 |
2.56321 |
[CC] GO:0043679 |
None
|
CHRM2, DRD2, OPRD1, OPRK1 |
2.44729 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ALPL, APP, AR, AXL, CA12, CA14, CA2, CA4, CA9, CHRM2, CSNK2A1, DRD1, DRD2, FLT3, HCAR2, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, MMP2, OPRD1, OPRK1, OPRM1, PIM1, PTPN1, SRC, TERT |
2.39216 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, CA2, CA4, CA9, CHRM2, DRD1, DRD2, HTR2A, MET, OPRD1, OPRM1, SIGMAR1, SRC |
2.36341 |
[CC] GO:0044306 |
None
|
CHRM2, DRD2, OPRD1, OPRK1 |
2.12087 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, APP, AR, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PTPN1, RORC, TYR, XDH |
12.9922 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HTR1A, HTR2A, HTR7, IGF1R, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PDE10A, PDE3A, PDE3B, PDE5A, PGR, PIM1, PPARA, PTPN1, RORC, SRC, TERT, TYR, XDH |
10.1157 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.90465 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
8.13126 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, HTR1A, HTR2A, HTR7, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PDE10A, PDE3A, PDE3B, PDE5A, PGR, PIM1, PPARA, PTPN1, RORC, TERT, TYR, XDH |
8.06803 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FLT3, FUT7, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, MAOB, MET, MIF, MMP1, MMP12, MMP2, MMP9, PDE10A, PDE3A, PDE3B, PDE5A, PIM1, PTPN1, SENP6, SRC, TERT, TYR, XDH |
8.01485 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AR, AXL, CHRM2, DRD1, DRD2, FLT3, HCAR2, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, NR3C1, NR3C2, OPRD1, OPRK1, OPRM1, PGR, PPARA, RORC, SIGMAR1 |
7.07586 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
6.78385 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AR, AXL, CHRM2, DRD1, DRD2, FLT3, HCAR2, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, NR3C1, NR3C2, OPRD1, OPRK1, OPRM1, PGR, PPARA, RORC, SIGMAR1 |
6.28648 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HMGCR, HSD17B1, HSD17B2, MAOB, TYR, XDH |
6.24685 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.2285 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AR, AXL, CHRM2, DRD1, DRD2, FLT3, HCAR2, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, NR3C1, NR3C2, OPRD1, OPRK1, OPRM1, PGR, PPARA, RORC, SIGMAR1 |
6.08313 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TYR |
6.02609 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA7, CA9, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PPARA, PTPN1, RORC |
5.71815 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AR, AXL, CHRM2, DRD1, DRD2, FLT3, HCAR2, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, NR3C1, NR3C2, OPRD1, OPRK1, OPRM1, PGR, PPARA, RORC, SIGMAR1 |
5.66583 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, XDH |
5.62838 |
[MF] GO:0004985 |
None
|
OPRD1, OPRK1, OPRM1, SIGMAR1 |
5.50166 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.49831 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
5.4015 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, SRC |
5.21141 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PDE10A, PDE3A, PDE3B, PDE5A, PGR, PIM1, PPARA, PTPN1, RORC, TERT, TYR, XDH |
5.20677 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6, DRD1, DRD2, FLT3, HTR2A, IGF1R, KDR, MET, PDE10A, PIM1, PPARA, SIGMAR1, SRC |
5.01794 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, SRC |
4.99772 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, NR3C1, NR3C2, PGR, PPARA, RORC |
4.7605 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TYR |
4.64436 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
4.52151 |
[MF] GO:0030594 |
None
|
CHRM2, DRD1, DRD2, HTR1A, HTR2A, HTR7, OPRM1 |
4.50395 |
[MF] GO:0047555 |
None
|
PDE10A, PDE3A, PDE3B, PDE5A |
4.50093 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HMGCR, HSD17B1, MAOB, SRC, XDH |
4.40508 |
[MF] GO:0099528 |
None
|
CHRM2, HTR1A, HTR2A, HTR7, OPRM1 |
4.30731 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, HTR1A, HTR2A, HTR7 |
4.2843 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, AXL, CHRM2, DRD1, DRD2, FLT3, HCAR2, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1 |
4.02285 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, AXL, CHRM2, DRD1, DRD2, FLT3, HCAR2, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1 |
4.02285 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, CBR1, HMGCR, HSD17B1, HSD17B2, XDH |
3.95353 |
[MF] GO:0005496 |
steroid binding
|
AR, HSD17B1, NR3C1, NR3C2, PGR, RORC |
3.92683 |
[MF] GO:0004114 |
None
|
PDE10A, PDE3A, PDE3B, PDE5A |
3.63989 |
[MF] GO:0004112 |
None
|
PDE10A, PDE3A, PDE3B, PDE5A |
3.57263 |
[MF] GO:0008227 |
None
|
CHRM2, DRD2, HTR1A, HTR2A, HTR7 |
3.54238 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.3917 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, CBR1, HMGCR, HSD17B1, HSD17B2 |
3.22695 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
3.21336 |
[MF] GO:0043176 |
None
|
HTR1A, HTR2A, HTR7 |
3.11269 |
[MF] GO:0051378 |
None
|
HTR1A, HTR2A, HTR7 |
3.11269 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.97644 |
[MF] GO:0004119 |
None
|
PDE3A, PDE3B |
2.92144 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.92144 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, HSD17B1, IGF1R, NR3C1 |
2.85148 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, CHRM2, DRD1, DRD2, HCAR2, HTR1A, HTR2A, HTR7, OPRD1, OPRK1, OPRM1, SIGMAR1 |
2.78715 |
[MF] GO:0004115 |
None
|
PDE10A, PDE3A, PDE3B |
2.75423 |
[MF] GO:0016788 |
None
|
ACHE, ADORA1, ALPL, CA1, CA2, CDC25B, CES2, PDE10A, PDE3A, PDE3B, PDE5A, PTPN1 |
2.73589 |
[MF] GO:0008081 |
None
|
ADORA1, PDE10A, PDE3A, PDE3B, PDE5A |
2.73246 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, PGR, PPARA, RORC |
2.6012 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, PGR, PPARA, RORC |
2.6012 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR2A, HTR7 |
2.51939 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, CYP19A1, CYP1A2, MAOB, XDH |
2.44729 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.399 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, FLT3, HMGCR, HSD17B1, HTR1A, HTR2A, HTR7, IGF1R, KDR, MAOB, MET, MMP12, NR3C1, NR3C2, PDE10A, PDE3A, PDE5A, PGR, PIM1, PPARA, PTPN1, RORC, SRC, TERT, XDH |
2.37447 |
[MF] GO:0042578 |
None
|
ADORA1, ALPL, CDC25B, PDE10A, PDE3A, PDE3B, PDE5A, PTPN1 |
2.35889 |
[MF] GO:0042923 |
None
|
OPRD1, OPRK1, OPRM1 |
2.34143 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, FLT3, HTR2A, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SRC |
2.33776 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, APP, BCL2, CSNK2A1, DRD2, FLT3, HMGCR, IGF1R, KDR, MAOB, MET, MIF, MMP9, PGR, TERT, TYR, XDH |
2.26473 |
[MF] GO:0004993 |
None
|
HTR1A, HTR2A, HTR7 |
2.24959 |
[MF] GO:0099589 |
None
|
HTR1A, HTR2A, HTR7 |
2.24959 |
[MF] GO:0051721 |
None
|
BCL2, HMGCR, PTPN1 |
2.08002 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, FLT3, HTR2A, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SRC |
2.02668 |